On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...